- Home
- JANX vs TRST Comparison
JANX vs TRST Comparison
Compare JANX & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | TRST |
|---|---|---|
| Founded | 2017 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 858.9M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | JANX | TRST |
|---|---|---|
| Price | $17.54 | $56.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $33.81 | N/A |
| AVG Volume (30 Days) | ★ 751.0K | 81.3K |
| Earning Date | 11-09-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 2.81% |
| EPS Growth | N/A | ★ 26.46 |
| EPS | N/A | ★ 1.89 |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | $194.24 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $37.20 |
| 52 Week High | $35.34 | $59.28 |
Technical Indicators
Market Signals| Indicator | JANX | TRST |
|---|---|---|
| Relative Strength Index (RSI) | 51.36 | 56.49 |
| Support Level | $15.90 | $55.29 |
| Resistance Level | $19.16 | $59.13 |
| Average True Range (ATR) | 0.83 | 1.13 |
| MACD | 0.07 | 0.34 |
| Stochastic Oscillator | 48.72 | 71.43 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.